PMV Pharmaceuticals Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
PMV Pharmaceuticals Inc
Did you know?
Capital expenditures decreased by 100% from FY24 to FY25.
Current Price
$1.40
+0.72%Profile
Valuation (TTM)
Market Cap$74.50M
P/E-0.96
EV—
P/B0.71
Shares Out53.21M
P/Sales—
Revenue$0.00
EV/EBITDA—
PMV Pharmaceuticals Inc (PMVP) Stock Analysis
Market Cap$74.50M
Current Price$1.40
P/E Ratio-0.96
Forward P/E—
PEG Ratio0.04
EPS$-1.48
Book Value$1.97
P/B Ratio0.71
PMVP Financial Charts
FCF vs CAPEX
FCFCAPEX
Cash vs Debt
Net Cash: 37M
Revenue
—
FY19
—
FY20
—
FY21
—
FY22
—
FY23
—
FY24
—
FY25
Net Income
—
FY19
—
FY20
—
FY21
—
FY22
—
FY23
—
FY24
—
FY25
PMVP 52-Week Range
$0.84
$1.80
50-Day MA: $1.42200-Day MA: $1.34
Did you know?
Price sits at 58% of its 52-week range.
PMV Pharmaceuticals Inc (PMVP) Financial Summary
PMV Pharmaceuticals Inc (PMVP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ. The stock currently trades at $1.40 with a market capitalization of $74.50M.
Key valuation metrics include a P/E ratio of -0.96, price-to-book ratio of 0.71, and EPS of $-1.48. and return on equity of -74.2%.
PMVP Key Financial Metrics
| Metric | Value |
|---|---|
| Market Cap | $74.50M |
| P/E Ratio | -0.96 |
| EPS | $-1.48 |
| P/B Ratio | 0.71 |
| Return on Equity | -74.2% |
| Debt/Equity | 0.01 |
PMVP Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY19 | $0.00 | $-25.35M |
| FY20 | $0.00 | $-34.44M |
| FY21 | $0.00 | $-57.85M |
| FY22 | $0.00 | $-73.32M |
| FY23 | $0.00 | $-68.96M |
| FY24 | $0.00 | $-58.71M |
| FY25 | $0.00 | $-77.74M |
About PMV Pharmaceuticals Inc
PMV Pharmaceuticals Inc
PMVP Free Cash Flow
PMV Pharmaceuticals Inc generated $-73.58M in trailing twelve-month free cash flow, representing an FCF yield of -98.76%. This low FCF yield may reflect heavy reinvestment or growth spending.
PMVP Shares Outstanding
PMV Pharmaceuticals Inc has 0.05 billion shares outstanding at a share price of $1.40, giving it a market capitalization of $74.50M.